ASX - Delayed Quote AUD

4DMedical Limited (4DX.AX)

0.2700

-0.0100

(-3.57%)

At close: 4:10:19 PM GMT+10

Discover 3 Promising ASX Penny Stocks Under A$400M Market Cap

The Australian share market is showing signs of an upswing, with ASX 200 futures indicating a modest gain as investors react to potential shifts in inflation data and interest rate expectations. Amid these broader market dynamics, penny stocks remain an intriguing area for investors seeking opportunities in smaller or newer companies. Despite their vintage name, penny stocks can offer surprising value when backed by strong financials, and this article explores three such promising candidates...

Simply Wall St. 2 months ago

FDMDF

PBTHF

LM8.AX
3 ASX Penny Stocks With Market Caps Under A$400M

The Australian market has recently experienced a downturn, with the ASX closing the year on a two-day losing streak and most sectors ending in the red. In such fluctuating conditions, identifying stocks with potential resilience and growth becomes crucial. Penny stocks, despite being an older term, remain relevant as they often represent smaller or newer companies that might offer unique opportunities when backed by solid financial health.

Simply Wall St. 3 months ago

OZFRY

FDMDF

TDMMF
4DMedical Full Year 2024 Earnings: Misses Expectations

4DMedical ( ASX:4DX ) Full Year 2024 Results Key Financial Results Net loss: AU$36.0m (loss widened by 14% from FY...

Simply Wall St. 6 months ago

FDMDF
Will 4DMedical (ASX:4DX) Spend Its Cash Wisely?

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Simply Wall St. 8 months ago

FDMDF

Performance Overview

Return	4DX.AX	S&P/ASX 200 [XJO] (^AXJO)
YTD	-43.75%	-4.20%
1-Year	-55.37%	+2.19%
3-Year	-64.94%	+4.60%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

4DMedical Limited (4DX.AX)

Discover 3 Promising ASX Penny Stocks Under A$400M Market Cap

3 ASX Penny Stocks With Market Caps Under A$400M

4DMedical Full Year 2024 Earnings: Misses Expectations

Will 4DMedical (ASX:4DX) Spend Its Cash Wisely?

Performance Overview